These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The pathology of multiple sclerosis and its evolution. Lassmann H Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616 [TBL] [Abstract][Full Text] [Related]
4. Pathology and etiology in multiple sclerosis: a review. Kraft AM; Wessman HC Phys Ther; 1974 Jul; 54(7):716-20. PubMed ID: 4608763 [No Abstract] [Full Text] [Related]
5. [Etiopathogenesis of multiple sclerosis]. Ketelaer CJ Rev Med Liege; 1970 Nov; 25(22):727-37. PubMed ID: 5515909 [No Abstract] [Full Text] [Related]
7. Antibodies to oligodendroglia in patients with multiple sclerosis. Abramsky O; Lisak RP; Silberberg DH; Pleasure DE N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246 [TBL] [Abstract][Full Text] [Related]
8. Oligodendrocytes: the putative target cells of multiple sclerosis. Abramsky O Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297 [No Abstract] [Full Text] [Related]
9. Animal models of multiple sclerosis. Fleming JO Mayo Clin Proc; 1985 Jul; 60(7):490-2. PubMed ID: 4010344 [No Abstract] [Full Text] [Related]
10. [The immunology of multiple sclerosis: changing concepts]. Vermersch P Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F138-46. PubMed ID: 18680832 [No Abstract] [Full Text] [Related]
11. [Etiology and pathogenesis of multiple sclerosis]. Marchenkova RL; Komandenko NI; Skoromets AA Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(2):129-33. PubMed ID: 425754 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathy associated with multiple sclerosis. Tsung SH Ann Clin Lab Sci; 1978; 8(6):472-5. PubMed ID: 736511 [TBL] [Abstract][Full Text] [Related]
15. Oligodendrocyte apoptosis before immune attack in multiple sclerosis? Pender MP Ann Neurol; 2005 Jan; 57(1):158; author reply 158-9. PubMed ID: 15622546 [No Abstract] [Full Text] [Related]
16. The aetiology and pathogenesis of multiple sclerosis. Adams CW; Hallpike JF Guys Hosp Rep; 1969; 118(2):263-86. PubMed ID: 4896181 [No Abstract] [Full Text] [Related]
17. Lymphocyte phenotypes in the multiple sclerosis lesion--what do they mean? Zweiman B; Lisak RP Ann Neurol; 1986 Jun; 19(6):588-9. PubMed ID: 2942098 [No Abstract] [Full Text] [Related]
18. Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis. McFarland HI; Lobito AA; Johnson MM; Nyswaner JT; Frank JA; Palardy GR; Tresser N; Genain CP; Mueller JP; Matis LA; Lenardo MJ J Immunol; 1999 Feb; 162(4):2384-90. PubMed ID: 9973519 [TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis--the plaque and its pathogenesis. Frohman EM; Racke MK; Raine CS N Engl J Med; 2006 Mar; 354(9):942-55. PubMed ID: 16510748 [No Abstract] [Full Text] [Related]
20. The possible role of measles virus in the pathogenesis of multiple sclerosis. Pette E; Palacios O Int Arch Allergy Appl Immunol; 1969; 36():Suppl:102-8. PubMed ID: 4392027 [No Abstract] [Full Text] [Related] [Next] [New Search]